Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Akcea Therapeutics Virtual Exhibit Hall - EMG/EEG, and Neurophysiology ...
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in ...
Akcea reports positive topline Phase 2 data from cardiometabolic ...
Ionis et Akcea célèbrent la journée de sensibilisation au SCF avec les ...
Akcea Therapeutics Canada souligne le lancement officiel d'un programme ...
Akcea Retains The Chase Group to Secure Senior HR Leader for the ...
Buy Akcea Therapeutics Stock – AKCA Stock Quote Today & Investment ...
Akcea entra em Portugal com a GCI – Marketeer
AKCA Stock Price, News & Analysis | Akcea
Akcea Therapeutics UK
Member Spotlight: Q&A with Akcea Therapeutics - MassBio
Akcea and Ionis Receive FDA Approval of TEGSEDI™
Akcea Therapeutics, Inc. IPO Preview – IPO Boutique
Akcea Therapeutics, Inc. - AnnualReports.com
Were Hedge Funds Right About Akcea Therapeutics, Inc. (AKCA)? - Insider ...
Akcea taps first commercial chief as Waylivra debuts and pipeline ...
Akcea Therapeutics Soars as It Readies Its First Drug Launch | The ...
Akcea and Ionis Gear Up for Second Attempt at Getting Waylivra FDA ...
Why Akcea Therapeutics Stock Skyrocketed Today | The Motley Fool
Ionis agrees to take a remaining Stake in Akcea Therapeutics for $500m
Cambridge-based Ionis spinout Akcea plots $100M IPO - Boston Business ...
Akcea Therapeutics Inc: Akcea Therapeutics genetic disease treatment ...
Akcea Therapeutics Announces Positive Phase 2 Study Results – ISPE Boston
Brett F. on LinkedIn: Akcea and Ionis Report Top-line Results from the ...
PPT - The Stages of Hereditary Amyloidosis - Akcea Therapeutics ...
FDA Approves Akcea Rare Disease Drug With A Black Box Warning - STAT ...
FDA rejects Akcea rare-disease drug that uses gene-blocking technology ...
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia ...
Akcea Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Akcea and Ionis' Triglyceride-Lowering Drug Works in Mid-Stage Clinical ...
Ionis strikes deal to buy back lipid disease spinout Akcea - Biotech Today
Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 ...
Why Akcea Therapeutics, Inc. Is Soaring While Ionis Pharmaceuticals Is ...
Akcea begins Phase IIb trial of AKCEA-APO(a)-L to treat high Lp(a) and ...
Akcea Therapeutics 2026 Company Profile: Valuation, Investors ...
Akcea Therapeutics Genetic Disease Treatment Gets FDA Clearance - Drug ...
「澳洲國慶日」悉尼韓裔社區分享多元文化 | AKCEA | 韓國文化交流協會 | 大紀元
Precio de las acciones de akcea therapeutics inc - leyfrutcacomp’s blog
Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the ...
Akcea Therapeutics plunges 20% as 3 executives suddenly depart the ...
“澳洲国庆日”悉尼韩裔社区分享多元文化 | AKCEA | 韩国文化交流协会 | 大纪元
Akcea Therapeutics, Inc.: 药物管线_专利_临床试验_投融营收_最新药物:Volanesorsen，Inotersen ...
Akcea Stock Surges 60% After Ionis Takeover | AskTraders.com
Akcea Therapeutics reducirá cerca del 10% su plantilla de empleados ...
Q&A: Akcea Therapeutics CEO Paula Soteropoulos on STEM education and ...
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam ...
Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for ...
Our Story - Pioneering Innovation in Therapeutics | IONIS
2018 Sponsors – Toronto Neurology Update
輝瑞獲反義RNA療法公司Akcea新型心血管藥物授權達2.5億美元-環球生技月刊
AAHS - 2021 AAHS Virtual Webinar Series
Safety and efficacy of AKCEAAPOaLRx to lower lipoproteina
Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels ...
Slides - Triglyceride Forum
AKCEA‐TTR‐LRx produced dose‐dependent reductions in TTR mRNA in human ...
Akcea를 통해본 핵산치료제 시장의 동향과 전망 : 네이버 블로그
探针资本_上市公司分析：Akcea Therapeutics_Ionis
Marla Spiegel (@MarlaSpiegel) / Twitter
P010. Evaluation of the Efficacy and Safety of AKCEA-TTR-LRx (ION ...
The Chase Group, Inc.
#akcea #raredisease #digital #patients | Andy Caldwell
Flow of study participants in phase 1 trial of AKCEA‐TTR‐LRx ...
graphic
Découvrir nos clients - syntagme
「澳洲國慶日」悉尼韓裔社區分享多元文化 | 韓國文化交流協會（AKCEA） | 傳統文化 | 大紀元
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of ...
靶向RNA疗法！辉瑞、Akcea达成15亿美元合作；以基因编辑疗法“攻克”血友病！诺和诺德... 大公司 靶向RNA疗法！ 辉瑞 、Akcea ...
Lipodystrophy - We are excited to share the poster that was created ...
Akcea/Ionis' rare disease drug Waylivra set for EU market after ...
Jessica Patch :: Behance
Akcea, Ionis win over most FDA experts to their rare disease drug ...
Novartis to license Akcea-Ionis cardiac disease drug
pelacarsen-drug information-NextBiopharm™-ByDrug-Pharmcube Database
[김태억의 테크노트]'3배 급등' Akcea, 주목받는 이유 - 바이오스펙테이터
#akcea #ionis #mmmdiversity | Ionis Pharmaceuticals, Inc.
“澳洲国庆日”悉尼韩裔社区分享多元文化 | 韩国文化交流协会（AKCEA） | 传统文化 | 大纪元
%20Phase%202%20_11_9_18%20Tsimikas.png?itok=sc51lsYn)
